Is initial serum (1,3)-β-D-glucan truly associated with mortality in patients with candidaemia?

被引：3
作者：
Abe, M. [1 ]
Kimura, M. [1 ]
Araoka, H. [1 ,2 ]
Taniguchi, S. [3 ]
Yoneyama, A. [1 ,2 ]
机构：
[1] Toranomon Gen Hosp, Dept Infect Dis, Tokyo 1058470, Japan
[2] Okinaka Mem Inst Med Res, Tokyo, Japan
[3] Toranomon Gen Hosp, Dept Haematol, Tokyo 1058470, Japan
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2016年 / 22卷 / 06期
关键词：
D O I：
10.1016/j.cmi.2016.02.008
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：576 / 576
页数：1
相关论文
共 2 条
  • [1] Serum (1,3)-beta-D-glucan is an inefficient marker of breakthrough candidemia
    Abe, Masahiro
    Kimura, Muneyoshi
    Araoka, Hideki
    Taniguchi, Shuichi
    Yoneyama, Akiko
    [J]. MEDICAL MYCOLOGY, 2014, 52 (08) : 835 - 840
  • [2] Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control-control study
    Giacobbe, D. R.
    Del Bono, V.
    Trecarichi, E. M.
    De Rosa, F. G.
    Giannella, M.
    Bassetti, M.
    Bartoloni, A.
    Losito, A. R.
    Corcione, S.
    Bartoletti, M.
    Mantengoli, E.
    Saffioti, C.
    Pagani, N.
    Tedeschi, S.
    Spanu, T.
    Rossolini, G. M.
    Marchese, A.
    Ambretti, S.
    Cauda, R.
    Viale, P.
    Viscoli, C.
    Tumbarello, M.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2015, 21 (12) : 1106.e1 - 1106.e8
1